LPCN vs MDLZ · rev $309.5K vs P/E 30, rev $38.54B
Lipocine Inc (LPCN) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
LPCN currently screens at market cap $19.3M. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the LPCN and MDLZ stock pages for the full models.
Not investment advice.